CancerCare Manitoba Research

06/10/2026

CancerCare Manitoba Physician-Scientists Lead Practice-Changing Research

Two CancerCare Manitoba physician-scientists, Dr. Ryan Zarychanski and Dr. Brett Houston, helped lead a landmark Canadian study published in the New England Journal of Medicine.

The study found that a low-cost medication can reduce the need for blood transfusions during major surgery without increasing the risk of dangerous blood clots.

More than 8,300 patients participated, including over 5,000 people undergoing cancer surgery.

The findings could improve care for millions of patients worldwide and help conserve millions of units of blood every year.

A powerful example of Manitoba research making a global impact.

University of Manitoba

Read the full article https://www.cancercare.mb.ca/About-Us/communications-and-public-affairs/news-archive/CancerCare-Manitoba-physician-scientists-help-lead-landmark-study-published-in-New-England-Journal-of-Medicine

06/05/2026

06/02/2026

Congratulations to Dr. Athanasios Zovoilis and his team, who recently received a Manitoba Solutions Grant through Research Manitoba.

Their project, AI4Omics-MB, will explore how artificial intelligence can be applied to genetic data from Manitoba patients to improve cancer detection, support more personalized treatment, and enhance clinical decision-making.

By leveraging data from the Manitoba Tumour Bank and PrairieGen, this research is grounded in the needs of Manitoba patients, healthcare providers, and our healthcare system.

The project will also help build local expertise in AI and genomics, strengthen research partnerships, and further position Manitoba as a leader in AI-driven cancer care.

Learn more about the project and its potential impact: https://www.cancercare.mb.ca/About-Us/communications-and-public-affairs/news-archive/AI4Omics-MB-Using-Artificial-Intelligence-to-Advance-Cancer-Care-in-Manitoba

05/26/2026

05/20/2026

We are launching a new program to improve care for people living with Sickle Cell Disease (SCD).

We’re inviting individuals with SCD, as well as parents, guardians, and caregivers, to join small Zoom group discussions and share their lived experience to help shape future care.

Participants will receive an honourarium for their time.

If interested, please fill out the expression of interest form here https://forms.office.com/pages/responsepage.aspx?id=UmsbEbOCP0uzFBsYWEDdKgLiDNNONwRNoMciVvJ7c_FUMFFPMDdUWEowOTgwWDRDMDk1N1lDQzJKUC4u&route=shorturl

05/15/2026

Congratulations to CCMB Hematologist and University of Manitoba Professor Dr. Ryan Zarychanski on being awarded a Tier 1 Canada Research Chair in Clinical Trials.

This prestigious recognition is awarded to researchers who are internationally recognized leaders in their field and conducting groundbreaking research with significant impact.

Dr. Zarychanski’s work focuses on modernizing clinical trials by embedding them directly into patient care to improve outcomes, efficiency, and access for patients.